1035229-55-0Relevant academic research and scientific papers
The chemistry of 2-alkenyl-5(4H)-oxazolones. VIII acid-catalyzed reaction with alcohols
Heilmann, Steven M.,Moren, Dean M.,Krepski, Larry R.,Pathre, Sadanand V.,Rasmussen, Jerald K.,Stevens, John
, p. 12151 - 12160 (1998)
The acid-catalyzed reaction of 4,4-dimethyl-2-vinyl-5(4H)-oxazolone with primary alcohols proceeded with almost equal frequency at both C=C (Michael addition) and C=O (ring opening) groups; reaction with secondary and tertiary alcohols resulted in a modes
Design driven HtL: The discovery and synthesis of new high efficacy β2-agonists
Stocks, Michael J.,Alcaraz, Lilian,Bailey, Andrew,Bonnert, Roger,Cadogan, Elaine,Christie, Jadeen,Connolly, Stephen,Cook, Anthony,Fisher, Adrian,Flaherty, Alice,Hill, Stephen,Humphries, Alexander,Ingall, Anthony,Jordan, Stephen,Lawson, Mandy,Mullen, Alex,Nicholls, David,Paine, Stuart,Pairaudeau, Garry,St-Gallay, Stephen,Young, Alan
scheme or table, p. 4027 - 4031 (2011/08/06)
The design and synthesis of a new series of high efficacy β2-agonists devoid of the key benzylic alcohol present in previously described highly efficacious β2-agonists is reported. A hypothesis for the unprecedented level of efficacy is proposed based on considerations of β2-adrenoceptor crystal structure, other biophysical data and modeling studies.
AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES
-
Page/Page column 127-128, (2008/12/06)
The present invention provides compounds of formula (I), wherein k, Ar, R2, R3, R4, R5, R4', R5', R6, R7, A, D, m and E are as defined in the specification, processes
NOVEL BENZOTHIAZOLONE DERIVATIVES
-
Page/Page column 52, (2008/06/13)
The present invention provides compounds of formula (I) wherein e, R1, R2, R3, R4, R5, R4, R5, R6, R7, R7a, R7b, A, D, m and n are as
7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS
-
Page/Page column 49; 52; 57, (2008/06/13)
The present invention provides compounds of formula (I) wherein e, R1, R2, R3, R4, R5, R4', R5', R6, R7, A, D, m and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
